Also known as: Myasthaenia Gravis / Myasthenia gravis without (acute) exacerbation / Myasthenia gravis paralytica / Myasthenia gravis (disorder)
|A cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis.
|An alpha and beta-adrenergic agonist indicated to treat hypotension under anesthesia, allergic conditions, bronchial asthma, and nasal congestion.
|A cholinesterase inhibitor used in the symptomatic treatment of myasthenia gravis by improving muscle tone.
|A cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants.
|A complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults.